WINMEDIC Shines at WHX Labs Dubai 2026
On February 13, 2026, the global laboratory technology and diagnostics event, WHX Labs Dubai 2026, successfully concluded at the Dubai World Trade Centre. As an unprecedented industry gathering in the Middle East and North Africa region, the exhibition brought together professional visitors from over 180 countries and more than 4,800 leading companies worldwide.
Flagship Product Portfolio Draws Strong On-Site Engagement
At the exhibition, WINMEDIC's core products became focal points for pathologists, laboratory leaders, and distributors.
Win-120-Pro Fully Automated Digital Slide Scanner
With its high-speed performance, operational stability, and exceptional image clarity, the Win-120-Pro attracted significant hands-on interest. Many visitors recognized it as a reliable cornerstone for building modern digital pathology laboratories.
DP-Master AI Quantitative Analysis Software
This solution generated strong interest among research institutions and pharmaceutical companies. Multiple in-depth technical discussions were conducted regarding its applications in tumor immunotherapy response assessment and innovative drug development.
WinCyto AI Cervical Cytology Screening Software
As a powerful tool for advancing public health screening, WinCyto stood out for its high sensitivity and diagnostic efficiency. It offers a critical solution to challenges such as uneven distribution of diagnostic resources and the need for improved screening accuracy.
Deepening Professional Exchange and Expanding Global Partnerships
Throughout the exhibition, the WINMEDIC booth welcomed hundreds of professional visitors from the Middle East, Europe, Asia, and Africa. The team established preliminary cooperation intentions with several potential regional partners and engaged in practical discussions on topics such as localization strategies and clinical validation.
Through in-depth exchanges with global industry leaders, WINMEDIC gained valuable insights into evolving international market demands and trends, further strengthening the momentum behind its product innovation and global expansion strategy.
Driving the Future of Pathology Through Innovation
Participation in WHX Labs Dubai 2026 reinforced a clear industry direction: digitalization, intelligence, and precision are becoming irreversible trends in pathology diagnostics worldwide.
WINMEDIC remains committed to innovation-driven development and a customer-centric approach, continuously advancing smarter and more reliable digital pathology solutions.
While WHX Labs Dubai 2026 has come to a close, WINMEDIC's journey toward global leadership continues.
See You Again in 2027!
